Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 5, Issue : 3, Year : 2019
Article Page : 386-389
https://doi.org/10.18231/j.ijceo.2019.092
Abstract
Optical coherence tomography provides a high-resolution imaging of ocular tissues to improve the diagnosis and management of diabetic retinopathy by producing reliable, reproducible and objective retinal images especially in diabetic macular edema that can clearly only be detected with OCT. It enhances the ability to exactly diagnose diabetic macular edema, epiretinal membranes, vitreomacular or vitroretinal traction. OCT also helps in visualising morphological changes of the retina in diabetic retinopathy. It demonstrates that macular edema which is a complex clinical entity with various morphology. With the OCT, structural changes and quantitative assessment of macular edema have become feasible as determined with retinal thickness and volume.
Keywords: OCT, Diabetic retinopathy.
How to cite : Tadwalkar A, Karandikar S , Sharma P, Comparison of central macular thickness by optical coherence tomography (OCT) in normal and diabetic patients without diabetic retinopathy. Indian J Clin Exp Ophthalmol 2019;5(3):386-389
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.